TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tranexamic Acid for the Prevention of Postpartum Bleeding in Women With Anaemia: an International, Randomised, Double-blind, Placebo Controlled Trial.
Brief Summary: Postpartum haemorrhage (PPH) is responsible for about 100,000 maternal deaths every year, almost all of which occur in low and middle income countries. When given within three hours of birth, tranexamic acid reduces deaths due to bleeding in women with PPH by almost one third. However, for many women, treatment of PPH is too late to prevent death and severe morbidities. Over one-third of pregnant women in the world are anaemic and many are severely anaemic. We now want to do the WOMAN-2 trial to see if giving tranexamic acid can prevent PPH and other severe outcomes in women with moderate and severe anaemia.


Options:
A: Arm Label: Tranexamic acid group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tranexamic Acid, Procedure: Cesarean section | Arm Label: Control group; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Cesarean section | Intervention Type: DRUG; Name: Tranexamic Acid; Assigned to Arm(s): Tranexamic acid group | Intervention Type: PROCEDURE; Name: Cesarean section; Assigned to Arm(s): Control group, Tranexamic acid group
B: Arm Label: Tranexamic acid; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tranexamic Acid | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Tranexamic Acid; Assigned to Arm(s): Tranexamic acid | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: tranexamic acid; Type: ACTIVE_COMPARATOR; Interventions: Drug: transamin | Arm Label: saline; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: transamin; Assigned to Arm(s): tranexamic acid
D: Arm Label: Tranexamic acid; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tranexamic Acid | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Tranexamic Acid; Assigned to Arm(s): Tranexamic acid | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Assisting in Informing Decisions in Emergency Departments: (ED-AID) Study
Brief Summary: This study will test a patient decision aid about safe firearm storage during suicidal crisis. The investigators hypothesize that participants with higher quality decisions after the decision aid will be more likely to change their firearm storage to reduce access during the time of crisis.


Options:
A: Arm Label: COPESS and Treatment as usual; Type: ACTIVE_COMPARATOR; Interventions: Other: COPESS | Arm Label: Treatment as usual only; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: COPESS; Assigned to Arm(s): COPESS and Treatment as usual
B: Arm Label: therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive behavioural therapy | Arm Label: Standard treatment; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard treatment | Intervention Type: BEHAVIORAL; Name: Cognitive behavioural therapy; Assigned to Arm(s): therapy | Intervention Type: OTHER; Name: Standard treatment; Assigned to Arm(s): Standard treatment
C: Arm Label: Decision Aid Group; Type: EXPERIMENTAL; Interventions: Behavioral: Decision Aid | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Decision Aid; Assigned to Arm(s): Decision Aid Group
D: Arm Label: Treatment as Usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment As Usual | Arm Label: Dialectical Behavior Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Dialectical Behavior Therapy | Intervention Type: BEHAVIORAL; Name: Dialectical Behavior Therapy; Assigned to Arm(s): Dialectical Behavior Therapy | Intervention Type: BEHAVIORAL; Name: Treatment As Usual; Assigned to Arm(s): Treatment as Usual

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Erector Spinae Plane Block With Thoracic Paravertebral Block for Breast Surgery
Brief Summary: Postoperative analgesia in breast surgery is a difficult and overworked issue due to etensive surgery and complex innervation of the breast. Erector spinae plane block (ESB) is a new defined and promising regional anesthesia technique for thoracic analgesia. Main purpose of this study is to compare the analgesic effect of ultrasound guided ESB with thoracic paravertebral block - the golden standard method for postoperative regional analgesia technique in breast surgery.


Options:
A: Arm Label: erector spinae block; Type: EXPERIMENTAL; Interventions: Procedure: erector spinae block | Arm Label: serratus anterior block; Type: EXPERIMENTAL; Interventions: Procedure: serratus plane block | Arm Label: intravenous morphine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Morphine Sulfate | Intervention Type: PROCEDURE; Name: serratus plane block; Assigned to Arm(s): serratus anterior block | Intervention Type: PROCEDURE; Name: erector spinae block; Assigned to Arm(s): erector spinae block | Intervention Type: DRUG; Name: Morphine Sulfate; Assigned to Arm(s): intravenous morphine
B: Arm Label: Erector Spinae Plane Block; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Erector Spinae Plane Block - Ultrasound guided | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Erector Spinae Plane Block - Ultrasound guided; Assigned to Arm(s): Erector Spinae Plane Block
C: Arm Label: ESP group; Type: ACTIVE_COMPARATOR; Interventions: Device: Intravenous morphine patient controlled device, Other: Erector Spinae Plane Block | Arm Label: TPVB group; Type: ACTIVE_COMPARATOR; Interventions: Device: Intravenous morphine patient controlled device, Other: Thoracic Paravertebral Block | Arm Label: Control Group; Type: OTHER; Interventions: Device: Intravenous morphine patient controlled device | Intervention Type: DEVICE; Name: Intravenous morphine patient controlled device; Assigned to Arm(s): Control Group, ESP group, TPVB group | Intervention Type: OTHER; Name: Erector Spinae Plane Block; Assigned to Arm(s): ESP group | Intervention Type: OTHER; Name: Thoracic Paravertebral Block; Assigned to Arm(s): TPVB group
D: Arm Label: Erector Spinae Plane Block; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Erector Spinae Plane Block | Arm Label: Deep and Superficial Serratus Anterior Plane Block; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Deep and Superficial Serratus Anterior Plane Block | Intervention Type: PROCEDURE; Name: Erector Spinae Plane Block; Assigned to Arm(s): Erector Spinae Plane Block | Intervention Type: PROCEDURE; Name: Deep and Superficial Serratus Anterior Plane Block; Assigned to Arm(s): Deep and Superficial Serratus Anterior Plane Block

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Erector Spinae Plane Block With Thoracic Paravertebral Block for Breast Surgery
Brief Summary: Postoperative analgesia in breast surgery is a difficult and overworked issue due to etensive surgery and complex innervation of the breast. Erector spinae plane block (ESB) is a new defined and promising regional anesthesia technique for thoracic analgesia. Main purpose of this study is to compare the analgesic effect of ultrasound guided ESB with thoracic paravertebral block - the golden standard method for postoperative regional analgesia technique in breast surgery.


Options:
A: Arm Label: Group I (Control); Type: PLACEBO_COMPARATOR; Interventions: Procedure: Erector Spinae Plan Block | Arm Label: Group II (ESP); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Erector Spinae Plan Block | Arm Label: Group III(OSTAP); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Oblique subcostal TAP | Intervention Type: PROCEDURE; Name: Erector Spinae Plan Block; Assigned to Arm(s): Group I (Control), Group II (ESP) | Intervention Type: PROCEDURE; Name: Oblique subcostal TAP; Assigned to Arm(s): Group III(OSTAP)
B: Arm Label: Erector Spinae (single injection); Type: EXPERIMENTAL; Interventions: Drug: Erector Spinae (single injection) | Arm Label: Paravertebral (single injection); Type: ACTIVE_COMPARATOR; Interventions: Drug: Paravertebral (single injection) | Intervention Type: DRUG; Name: Erector Spinae (single injection); Assigned to Arm(s): Erector Spinae (single injection) | Intervention Type: DRUG; Name: Paravertebral (single injection); Assigned to Arm(s): Paravertebral (single injection)
C: Arm Label: ESP group; Type: ACTIVE_COMPARATOR; Interventions: Device: Intravenous morphine patient controlled device, Other: Erector Spinae Plane Block | Arm Label: TPVB group; Type: ACTIVE_COMPARATOR; Interventions: Device: Intravenous morphine patient controlled device, Other: Thoracic Paravertebral Block | Arm Label: Control Group; Type: OTHER; Interventions: Device: Intravenous morphine patient controlled device | Intervention Type: DEVICE; Name: Intravenous morphine patient controlled device; Assigned to Arm(s): Control Group, ESP group, TPVB group | Intervention Type: OTHER; Name: Erector Spinae Plane Block; Assigned to Arm(s): ESP group | Intervention Type: OTHER; Name: Thoracic Paravertebral Block; Assigned to Arm(s): TPVB group
D: Arm Label: Erector Spinae Plane Block; Type: ACTIVE_COMPARATOR; Interventions: Procedure: regional anaesthesia with Levobupivicaine 0.25% 30mls with two methods either erector spinae plane block or serratus anterior plane block | Arm Label: Serratus Anterior Plane Block; Type: EXPERIMENTAL; Interventions: Procedure: regional anaesthesia with Levobupivicaine 0.25% 30mls with two methods either erector spinae plane block or serratus anterior plane block | Intervention Type: PROCEDURE; Name: regional anaesthesia with Levobupivicaine 0.25% 30mls with two methods either erector spinae plane block or serratus anterior plane block; Assigned to Arm(s): Erector Spinae Plane Block, Serratus Anterior Plane Block

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Methylphenidate Late Formula to Reduce Cannabis Use in Young Cannabis-Related Patients and Attention Deficit Disorder Hyperactivity
Brief Summary: Abuse of psychoactive substances is a behavior belonging to the field of risk behaviors that begins and takes place during adolescence. These risk behaviors are a major public health problem in France and worldwide.

Cannabis is the first illicit drug consumed by adolescents in France. His experimentation progresses rapidly between 11 and 17 years. The relationship between cannabis use and mental health has been shown by several studies. In particular Attention Deficit Hyperactivity Disorder (ADHD), characterized by attention deficit, impulsivity and disabling motor hyperactivity and beginning before 12 years of age (DSM-5), is a major risk factor for the consumption of cannabis. ADHD is a common condition (9% of children and 5% of adults), but often undiagnosed or untreated. It has been shown that the treatment of ADHD in childhood protects the consumption of psychoactive products during adolescence or adulthood. However, to our knowledge there is no study showing that treatment with methylphenidate in an ADHD patient - not treated - but already a cannabis user, was a positive prognostic factor in the decrease in cannabis use.


Options:
A: Arm Label: Medication Arm; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vyvanse, Drug: Methylphenidate | Arm Label: Behavioral Parent Training Arm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Behavioral Parent Training | Intervention Type: DRUG; Name: Vyvanse; Assigned to Arm(s): Medication Arm | Intervention Type: BEHAVIORAL; Name: Behavioral Parent Training; Assigned to Arm(s): Behavioral Parent Training Arm | Intervention Type: DRUG; Name: Methylphenidate; Assigned to Arm(s): Medication Arm
B: Arm Label: Ritalin LA; Type: EXPERIMENTAL; Interventions: Drug: Ritalin LA (methylphenidate hydrochloride extended release) | Intervention Type: DRUG; Name: Ritalin LA (methylphenidate hydrochloride extended release); Assigned to Arm(s): Ritalin LA
C: Arm Label: Adhansia XR; Type: EXPERIMENTAL; Interventions: Drug: Adhansia XR | Arm Label: Concerta; Type: ACTIVE_COMPARATOR; Interventions: Drug: Concerta | Intervention Type: DRUG; Name: Adhansia XR; Assigned to Arm(s): Adhansia XR | Intervention Type: DRUG; Name: Concerta; Assigned to Arm(s): Concerta
D: Arm Label: Methylphenidate; Type: EXPERIMENTAL; Interventions: Drug: Methylphenidate | Arm Label: Matching Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Matching Placebo | Intervention Type: DRUG; Name: Methylphenidate; Assigned to Arm(s): Methylphenidate | Intervention Type: OTHER; Name: Matching Placebo; Assigned to Arm(s): Matching Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Methylphenidate Late Formula to Reduce Cannabis Use in Young Cannabis-Related Patients and Attention Deficit Disorder Hyperactivity
Brief Summary: Abuse of psychoactive substances is a behavior belonging to the field of risk behaviors that begins and takes place during adolescence. These risk behaviors are a major public health problem in France and worldwide.

Cannabis is the first illicit drug consumed by adolescents in France. His experimentation progresses rapidly between 11 and 17 years. The relationship between cannabis use and mental health has been shown by several studies. In particular Attention Deficit Hyperactivity Disorder (ADHD), characterized by attention deficit, impulsivity and disabling motor hyperactivity and beginning before 12 years of age (DSM-5), is a major risk factor for the consumption of cannabis. ADHD is a common condition (9% of children and 5% of adults), but often undiagnosed or untreated. It has been shown that the treatment of ADHD in childhood protects the consumption of psychoactive products during adolescence or adulthood. However, to our knowledge there is no study showing that treatment with methylphenidate in an ADHD patient - not treated - but already a cannabis user, was a positive prognostic factor in the decrease in cannabis use.


Options:
A: Arm Label: Placebo First, then ORADUR®; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo First, then ORADUR® | Arm Label: ORADUR® First, then Placebo; Type: EXPERIMENTAL; Interventions: Drug: ORADUR® First, then Placebo | Intervention Type: DRUG; Name: Placebo First, then ORADUR®; Assigned to Arm(s): Placebo First, then ORADUR® | Intervention Type: DRUG; Name: ORADUR® First, then Placebo; Assigned to Arm(s): ORADUR® First, then Placebo
B: Intervention Type: DRUG; Name: methylphenidate hydrochloride; Assigned to Arm(s): N/A
C: Arm Label: Methylphenidate; Type: EXPERIMENTAL; Interventions: Drug: Methylphenidate | Arm Label: Matching Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Matching Placebo | Intervention Type: DRUG; Name: Methylphenidate; Assigned to Arm(s): Methylphenidate | Intervention Type: OTHER; Name: Matching Placebo; Assigned to Arm(s): Matching Placebo
D: Arm Label: Methylphenidate Transdermal System; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methylphenidate Transdermal System | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Concerta; Type: ACTIVE_COMPARATOR; Interventions: Drug: Concerta | Intervention Type: DRUG; Name: Methylphenidate Transdermal System; Assigned to Arm(s): Methylphenidate Transdermal System | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Concerta; Assigned to Arm(s): Concerta

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Crowdsourced Intervention to Promote Hepatitis B and C Testing Among Men Who Have Sex With Men in China: a Nationwide Online Randomized Controlled Trial
Brief Summary: This is an online randomized controlled trial (RCT) comparing men who have sex with men (MSM) exposed to a crowdsourced intervention to MSM who did not receive the intervention to determine the effect on Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) testing. Participants will be randomly assigned in a 1:1 ratio to intervention or control using a computer-based allocation system. Participants will be assessed for primary and secondary outcomes four weeks after randomization.


Options:
A: Arm Label: Stepwise intervention; Type: EXPERIMENTAL; Interventions: Other: Customized text message invitation ( Step 1a), Other: Customized automatic phone call invitation (Step 1b), Other: Secretary phone call (Step 2), Other: Health professional face-to-face appointment (Step 3) | Arm Label: Written Letter; Type: ACTIVE_COMPARATOR; Interventions: Other: Written Letter | Intervention Type: OTHER; Name: Customized text message invitation ( Step 1a); Assigned to Arm(s): Stepwise intervention | Intervention Type: OTHER; Name: Customized automatic phone call invitation (Step 1b); Assigned to Arm(s): Stepwise intervention | Intervention Type: OTHER; Name: Secretary phone call (Step 2); Assigned to Arm(s): Stepwise intervention | Intervention Type: OTHER; Name: Health professional face-to-face appointment (Step 3); Assigned to Arm(s): Stepwise intervention | Intervention Type: OTHER; Name: Written Letter; Assigned to Arm(s): Written Letter
B: Arm Label: Crowdsourced intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Crowdsourced materials | Arm Label: Control; Type: OTHER; Interventions: Other: Control | Intervention Type: BEHAVIORAL; Name: Crowdsourced materials; Assigned to Arm(s): Crowdsourced intervention | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control
C: Arm Label: Multilevel Gaming Adherence; Type: EXPERIMENTAL; Interventions: Behavioral: Multilevel Gaming Adherence Intervention | Arm Label: Treatment as Usual +; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as Usual + | Intervention Type: BEHAVIORAL; Name: Multilevel Gaming Adherence Intervention; Assigned to Arm(s): Multilevel Gaming Adherence | Intervention Type: BEHAVIORAL; Name: Treatment as Usual +; Assigned to Arm(s): Treatment as Usual +
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile phone reminder | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Mobile phone reminder | Intervention Type: BEHAVIORAL; Name: Mobile phone reminder; Assigned to Arm(s): Control, Intervention

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Crowdsourced Intervention to Promote Hepatitis B and C Testing Among Men Who Have Sex With Men in China: a Nationwide Online Randomized Controlled Trial
Brief Summary: This is an online randomized controlled trial (RCT) comparing men who have sex with men (MSM) exposed to a crowdsourced intervention to MSM who did not receive the intervention to determine the effect on Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) testing. Participants will be randomly assigned in a 1:1 ratio to intervention or control using a computer-based allocation system. Participants will be assessed for primary and secondary outcomes four weeks after randomization.


Options:
A: Arm Label: Crowdsourced intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Crowdsourced materials | Arm Label: Control; Type: OTHER; Interventions: Other: Control | Intervention Type: BEHAVIORAL; Name: Crowdsourced materials; Assigned to Arm(s): Crowdsourced intervention | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control
B: Arm Label: Text-Based Adherence Game; Type: EXPERIMENTAL; Interventions: Behavioral: Text-Based Adherence Game, Behavioral: Standard of Care (SOC) | Arm Label: Standard of Care (SOC); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard of Care (SOC) | Intervention Type: BEHAVIORAL; Name: Text-Based Adherence Game; Assigned to Arm(s): Text-Based Adherence Game | Intervention Type: BEHAVIORAL; Name: Standard of Care (SOC); Assigned to Arm(s): Standard of Care (SOC), Text-Based Adherence Game
C: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: EpxBreastfeeding, Other: Baby book survey | Arm Label: Control; Type: OTHER; Interventions: Other: Baby book survey | Intervention Type: OTHER; Name: EpxBreastfeeding; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Baby book survey; Assigned to Arm(s): Control, Intervention
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention (text); Type: EXPERIMENTAL; Interventions: Behavioral: SmokefreeMOM Text | Arm Label: Intervention Plus (text+quitline); Type: EXPERIMENTAL; Interventions: Behavioral: SmokefreeMOM Text | Intervention Type: BEHAVIORAL; Name: SmokefreeMOM Text; Assigned to Arm(s): Intervention (text), Intervention Plus (text+quitline)

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Crowdsourced Intervention to Promote Hepatitis B and C Testing Among Men Who Have Sex With Men in China: a Nationwide Online Randomized Controlled Trial
Brief Summary: This is an online randomized controlled trial (RCT) comparing men who have sex with men (MSM) exposed to a crowdsourced intervention to MSM who did not receive the intervention to determine the effect on Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) testing. Participants will be randomly assigned in a 1:1 ratio to intervention or control using a computer-based allocation system. Participants will be assessed for primary and secondary outcomes four weeks after randomization.


Options:
A: Arm Label: The Cedar Project mHealth Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: The Cedar Project mHealth intervention | Arm Label: Comparison group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: The Cedar Project mHealth intervention; Assigned to Arm(s): The Cedar Project mHealth Intervention
B: Arm Label: Crowdsourced intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Crowdsourced materials | Arm Label: Control; Type: OTHER; Interventions: Other: Control | Intervention Type: BEHAVIORAL; Name: Crowdsourced materials; Assigned to Arm(s): Crowdsourced intervention | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control
C: Arm Label: Kilkari; Type: EXPERIMENTAL; Interventions: Other: Kilkari | Arm Label: Comparison; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Kilkari; Assigned to Arm(s): Kilkari
D: Arm Label: Motivational SMS; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational SMS | Arm Label: Travel Voucher; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational SMS, Behavioral: Travel Voucher | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Motivational SMS; Assigned to Arm(s): Motivational SMS, Travel Voucher | Intervention Type: BEHAVIORAL; Name: Travel Voucher; Assigned to Arm(s): Travel Voucher

Answer: B